The stock (CODX) has manifested an immediate reversal in direction within the early bell. Even though the PR had presented valuable insight on "High-Performance Detection of Cancer Mutation in Liquid Biopsy Samples" (TD Ameritrade). Be diligent as there could be a very quick and sporadic movement to the upside (bounce - bullish). Await confirmation prior to entering the market.